- 2014
- What's on? - 23.07.2014
2014 World Hepatitis Day
28 July 2014 is World Hepatitis Day. Millions of people across the world are infected by one of the five known viruses (A, B, C, D, E). Nearly 1.4 million people die from it every year. Hepatitis is an inflammation of the liver. It can have a viral or toxic origin (when alcohol abuse or […]
- Press releases - 21.07.2014
Radiotherapy ‘flashes’ to reduce side effects
Treating hard and fast seems to be a good way to limit the side effects of radiotherapy. This is the discovery made by researchers at the Curie Institute, Inserm and the Vaud University Hospital, published in Science Translational Medicine on 16 July.
Radiotherapy remains one of the benchmark local treatments for cancer patients: increasingly accurate, it consists of irradiating cancer cells to destroy them while preserving neighbouring healthy tissues and organs as much as possible. By increasing the intensity of the irradiation 1,000 times over a very short time, the researchers have shown that the efficacy remains the same, but healthy tissues are better protected. - Press releases - 18.07.2014
Working toward improved management of cranial trauma
Under normal conditions and because it cannot store oxygen, the brain cannot withstand being deprived of oxygen for more than a few minutes without risking serious consequences. After an accident (cranial trauma or stroke), emergency teams therefore try to restore cerebral oxygenation as quickly as possible. The faster and more precisely physicians work, the greater the chances of recovery. A multi-disciplinary team at the Grenoble Institute of Neuroscience (GIN, Inserm/ Grenoble-Alps University/Grenoble teaching hospital) comprising physicists, biologists and physicians (neurologists and anaesthetists) has developed a new method for measuring cerebral oxygenation using MRI. Besides being non-invasive, this technique identifies the least oxygenated areas of the brain with precision. Ultimately, it could be used to guide therapeutic interventions and make them more precise, less risky and more effective.
- What's on? - 17.07.2014
Chikungunya virus epidemic
The chikungunya virus is an infectious arboviral disease from the family Togaviridae. It comes from tropical regions and is transmitted by Aedes mosquitos. The virus is contracted by the mosquito when it bites an infected individual. It then becomes a carrier and can transmit the disease by biting a healthy person. There is no curative […]
- Press releases - 17.07.2014
What are the risks of post-traumatic stress disorder after an accident?
The team of Emmanuel Lagarde, research director at Inserm’s Research Centre for Epidemiology and Biostatistics (Inserm/University of Bordeaux) has studied the subsequent development of 1,300 people who were admitted to A&R between 2007 and 2009 for trauma.
- Press releases - 11.07.2014
100,000 women with breast implants monitored for 10 years
At the request of the Agence Nationale de Sécurité du Médicament et des produits de santé (ANSM) [French National Agency of Medicine and Health Products Safety], a group of researchers managed by Florent de Vathaire in Inserm Unit 1018 Centre for epidemiology and population health research is launching a study entitled LUCIE.
- Press releases - 11.07.2014
Ultrasound tracks odor representation in the brain
A new ultrasound imaging technique has provided the first ever in vivo visualization of activity in the piriform cortex of rats during odor perception. This deep-seated brain structure plays an important role in olfaction, and was inaccessible to functional imaging until now. This work also sheds new light on the still poorly known functioning of the olfactory system, and notably how information is processed in the brain.
- News in brief - 04.07.2014
L-Dopa treatment alleviates sleep disturbances associated with Parkinson’s disease
Patients suffering from Parkinson’s disease complain of severe sleep disturbances such as inability to fall asleep or, in contrast, periods of drowsiness during the day. While dopaminergic treatment dramatically improves the disease’s motor symptoms (calming tremors, for instance), its effects on sleep continued to be challenged, suggesting that the alteration of other (non-dopaminergic) neurons might […]
- Press releases - 04.07.2014
Laser bioprinting in Bordeaux : an innovative approach
One of the goals of the laboratory is to develop laser and microfabrication technologies with the aim of printing tissues in vitro and in vivo. The researchers in the laboratory were pioneers in Europe, developing laser-assisted bioprinting from 2005. This Inserm/University of Bordeaux joint research unit is one of a very few worldwide to use this process. The objective of Fabien Guillemot’s team is therefore not only to position cells in 3D, but to define and model the self-assembly dynamic of the printed cells.
- News in brief - 02.07.2014
New risk factors for alcohol abuse in adolescents brought to light
An international team involving researchers from INSERM, CEA and APHP in France have successfully modelled the risk factors for alcohol abuse during adolescence. The results of the study were published on Nature Magazine’s website on 2 July. In France, alcohol consumption most often begins in adolescence. Today, 80% of 17-year-olds admit to having consumed alcohol […]